Mouse monoclonal [TONI-1] to Angiotensin II Type 1 Receptor (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 185 SwissProtID: P30556...
1/4" to 1/8" Adapter for Reflectance Probe Holder...
... Glucagon-like peptide-1(7-36) amide (GLP-1), C-terminal reactive. ... shows <0.1% cross reactivity with the ... other related peptides such as hGLP-2, ... mammalian species. GLP-1 is identical in ...
Human/Mouse/Rat AMPK beta 1 Affinity Purified Polyclonal Ab...
Biology Products:... of Medicine scientists in the Department of Physiology and Cell Biology ... chromosome that may have significant implications for male infertility and contraception. ... This important discovery has been published in Nature ... biomedical research based upon the impact factor. , ...
... levels of carbon dioxide in the atmosphere are a ... The lack of atmospheric carbon dioxide (CO 2 ) ... their aquatic relatives, microalgae. , For plants and microalgae, ... their photosynthesis process that, along with sunlight, manufactures sugars ...
... Max Perutz was a campaigner for humanitarian causes, essayist, and ... has just been released by Cold Spring Harbor Laboratory Press. ... letters in the book What a Time I am ... life through his own vivid, erudite, and humorous pen. , ...
Other Biology News:Small RNAs can play critical roles in male infertility/contraception 2ISU researcher identifies protein that concentrates carbon dioxide in algae 2Selected personal letters of Max Perutz are released in new book 2(Date:12/11/2009)... Marrone Bio Innovations (MBI) today announces 2 new ... Hildreth joined MBI as Senior Vice President of ... commercial aspects of the company, including sales, marketing, ... Lam joined MBI as Vice President of Process ... scaling its broad pipeline of products to commercial ...
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... Corporation (Nasdaq: DNDN ) announced today that it ... of its common stock at a price to the ... to the underwriters a 30-day option to purchase up ... cover overallotments, if any. The offering is expected ... closing conditions. ,, J. P. Morgan Securities Inc. and ...
(Date:12/10/2009)... -- Endologix, Inc. (Nasdaq: ELGX ), developer ... today that Dan Lemaitre, former President and CEO ... Directors effective December 11, 2009. Endologix now ... ,, Franklin D. Brown, Chairman of the Board, ... to the Endologix Board of Directors. He ...
Breaking Biology Technology:Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Endologix Appoints Dan Lemaitre to its Board of Directors 2